Cargando…

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate

Purpose To evaluate acute and late genitourinary (GU) and gastrointestinal (GI) toxicity and the biochemical control of pure hypofractionated radiotherapy (without acceleration) for the treatment of prostate cancer. Methods and materials This phase II prospective trial evaluated low-risk and interme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gopaul, Darin, Panjwani, Dilip, Stephens, Robert F, Lock, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2018
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289559/ https://www.ncbi.nlm.nih.gov/pubmed/30546982 http://dx.doi.org/10.7759/cureus.3435

Ejemplares similares

Radiotherapy as a Single Modality in Primary Seminoma of the Prostate
por: Akingbade, Aquila, et al.
Publicado: (2021)

Long-term Local Control of Primary Non-small Cell Lung Cancer and Adrenal Oligometastasis with Stereotactic Body Radiotherapy: A Case Report
por: Krzywicki, Victoria, et al.
Publicado: (2019)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Short Course Hypofractionated Radiotherapy for Frail or Elderly Patients With Meningioma
por: Sarhan, Nasim, et al.
Publicado: (2020)

Comparison of Moderate Hypofractionated Volumetric-Modulated Arc Therapy Plans With and Without Flattening Filter for Localized Prostate Cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2021)

Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent Bevacizumab
por: Chaudhuri, Aadel A, et al.
Publicado: (2016)

Salvage Hypofractionated Radiotherapy in a Progressive Radiation-Induced Angiosarcoma: A Case Report
por: Bonzano, Elisabetta, et al.
Publicado: (2017)

Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
por: Youssef, Ashraf, et al.
Publicado: (2018)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer
por: Hughes, Ryan T, et al.
Publicado: (2019)

Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer
por: Li, Ming‐Hsien, et al.
Publicado: (2018)

Feasibility, Tolerance, and Quality of Life for Hypofractionation Versus Conventional Fractionation for Post-mastectomy Radiotherapy in Indian Patients
por: Malik, Deepika, et al.
Publicado: (2022)

A Comparative Prospective Study Between Conventional Chemo-Radiotherapy and Pure Accelerated Radiotherapy With Concurrent Chemotherapy for the Treatment of Locally Advanced Head and Neck Cancer
por: Das, Sumana M, et al.
Publicado: (2023)

Comparison of treatment plans for hypofractionated high‐dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
por: Lara, Pedro C., et al.
Publicado: (2022)

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

A Comparison Between Sequential Conventional and Hypofractionated Boost Following Whole-Breast Radiotherapy: A Propensity Score-Matched Analysis
por: Rajan, Jewel, et al.
Publicado: (2023)

Benchmarking halcyon ring delivery system for hypofractionated breast radiotherapy: Validation and clinical implementation of the fast‐forward trial
por: Pokhrel, Damodar, et al.
Publicado: (2023)

The impact of the three degrees‐of‐freedom fiducial marker‐based setup compared to soft tissue‐based setup in hypofractionated intensity‐modulated radiotherapy for prostate cancer
por: Tanabe, Satoshi, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases
por: Rodrigues, George, et al.
Publicado: (2019)

Adaptive radiation therapy strategies in the treatment of prostate cancer patients using hypofractionated VMAT
por: Siciarz, Pawel, et al.
Publicado: (2021)

TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial
por: Wan, Juefeng, et al.
Publicado: (2023)

Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium
por: Dincer, Neris, et al.
Publicado: (2022)

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study
por: Greco, Carlo, et al.
Publicado: (2022)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM
por: Jia, Angela, et al.
Publicado: (2016)

Dosimetric effects of positioning shifts using 6D‐frameless stereotactic Brainlab system in hypofractionated intracranial radiotherapy
por: Jin, Hosang, et al.
Publicado: (2016)

Evaluation of tumor motion effects on dose distribution for hypofractionated intensity‐modulated radiotherapy of non‐small‐cell lung cancer
por: Kang, Hyejoo, et al.
Publicado: (2010)

Hybrid Tomo‐Helical and Tomo‐Direct radiotherapy for localized prostate cancer
por: Karaca, Sibel, et al.
Publicado: (2021)

Definitive Radiotherapy for Locally Advanced Merkel Cell Carcinoma of the Head and Neck Region: A Case Report
por: Gortman, Aron
Publicado: (2019)

Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy – A Voxel-by-Voxel Analysis
por: Splinter, Mona, et al.
Publicado: (2020)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience
por: Sallabanda, Morena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iln22kj3ah9adnbavnf5gbdgs5